Skip to content
PresyoGamot
Menu

Metformin + Glibenclamide 500 mg + 5 mg in the Philippines

Quick answer

There is no DOH reference price for Metformin + Glibenclamide 500 mg + 5 mg; FDA Philippines lists 8 registered products at Metformin + Glibenclamide 500 mg + 5 mg (checked 2026-11-05): 8 under 6 brand names. It is a prescription (Rx) medicine. No unbranded generic is registered, so ask for the cheapest brand with the same generic name and strength; it is on the FDA VAT-exempt list, so no 12% VAT applies.

FDA-registered: 8 products6 brandsPrescription (Rx)VAT-exempt

Registered products

Registered Metformin + Glibenclamide 500 mg + 5 mg products

FDA Philippines lists 8 registrations under 6 brand names.

Registered Metformin + Glibenclamide 500 mg + 5 mg products
BrandStrength and formClassManufacturerReg.
Bemefor500mg/5mg Film-Coated TabletRxLek Pharmaceuticals D.D. (Slovenia)1
Diacom500 mg/ 5 mg Film-Coated TabletRxHovid Berhad (Malaysia)1
Glixfort500 mg/5 mg TabletRxAcme Formulation Pvt. Ltd. (India)1
Glucovance500 mg / 5 mg Film-Coated Tablet; 500 mg/ 5 mg Film-Coated TabletRxMerck Sante (France) +1 more2
Glycomet Plus500 mg / 5 mg Film-Coated Tablet; 500 mg/5 mg Film-Coated TabletRxPharmatec Pakistan (Pvt.) Ltd. (Pakistan)2
Glynova5mg/ 500mg TabletRxAcme Formulation Pvt. Ltd. (India)1

Source: FDA Philippines product registry, checked 2026-11-05. Look up any registration number at verification.fda.gov.ph.

Metformin + Glibenclamide 500 mg + 5 mg: products and brands

Other strengths

Paying less for metformin + glibenclamide

  • Ask for the generic

    Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works

  • Senior or PWD card

    20% off plus no VAT on your own medicines, with ID and prescription. What to bring

  • No VAT on this one

    It is on the FDA VAT-exempt list, so the 12% VAT should not be on your receipt. The list

Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.